CLINICAL SIGNIFICANCE OF VEGF AND UPA EVALUATION IN BREAST CANCER ArticleKostyleva O.I., Ovchinnikova L.K., Ermilova V.D., Mamedov U.R., Tereshkina I.V., Gritskevich M.V., Vorotnikov I.K., Kuznetsova O.V.Вопросы биологической, медицинской и фармацевтической химии. 2014. P.. 38-45
CLINICAL SIGNIFICANSE OF PROSTATE-SPECIFIC ANTIGEN IN BREAST CANCER PATIENTS ArticleSergeeva N.S., Karmakova T.A., Alentov I.I., Zikiryahodzhaev A.D., Ortabaeva D.R., Kaprin A.D.Siberian Journal of Oncology. Vol. 19. 2020. P.. 28-37
CLINICAL SPECIFICITIES AND RISK FACTORS OF EARLY FORMS OF PELVIC ORGAN PROLAPSE ArticleDubinskaya E.D., Babicheva I.A., Kolesnikova S.N., Dorfman M.F., Lapteva N.V.Voprosy Ginekologii, Akusherstva i Perinatologii. Vol. 14. 2015. P.. 5-11
CLINICAL-STATISTICAL ANALYSIS OF CHRONIC CARDIAC FAILURE ArticleTereschenko S.N., Demidova I.V., Levchuk N.N., Kobalava Z.D.Terapevticheskii Arkhiv. Vol. 71. 1999. P.. 42-46
CLINICAL STUDIES OF CHEMOTHERAPY EFFICACY IN COMBINATION WITH ANDROGENIC DEPRIVATION IN PATIENTS WITH OLIGOMETASTATIC HORMONE-SENSITIVE PROSTATE CANCER ArticlePopov S.V.Медицинский совет. 2019. P.. 170-175
CLINICAL STUDY (PHASE II) OF THE EFFICACY AND SAFETY OF LONGIDASE (SUPPOSITORIES) IN PATIENTS WITH ADHESIONS DUE TO PELVIC INFLAMMATORY DISEASE: A BLINDED, PLACEBO-CONTROLLED, RANDOMIZED STUDY ArticleПрилепская В.Н., Довлетханова Э.Р., Ледина А.В., Тагиева А.В.Gynecology. Vol. 26. 2024. P.. 141-149
CLINICAL STUDY'S RESULTS OF THE SAFETY OF THE RADIOPHARMACEUTICAL LABELED WITH 188RE DURING INTRAARTERIAL RADIOEMBOLIZATION; [РЕЗУЛЬТАТЫ КЛИНИЧЕСКОГО ИССЛЕДОВАНИЯ БЕЗОПАСНОСТИ РАДИОФАРМАЦЕВТИЧЕСКОГО ЛЕКАРСТВЕННОГО ПРЕПАРАТА С 188RE ПРИ ПРОВЕДЕНИИ ВНУТРИАРТЕРИАЛЬНОЙ РАДИОЭМБОЛИЗАЦИИ] ArticleKucherov V.V., Petrosyan A.P., Vlasova O.P., Sigov M.A., Tishchenko V.K., Spichenkova O.N., Stepanenko V.F., Shegay P.V., Ivanov S.A., Kaprin A.D.Radiation and Risk. Vol. 24. 2024. P.. 18-29
CLINICAL SUSPICION TO IMPORTED MALARIA: TRANSFUSION CASES AND DEATHS IN RUSSIA ArticleBaranova A.M., Sergiev V.P., Guzeeva T.M., Tokmalaev A.K.Инфекционные болезни: новости, мнения, обучение. Vol. 7. 2018. P.. 97-101
CLINICAL SYMPTOMS OF ACUTE CORONARY INSUFFICIENCY CORRELATE WITH GP-IIIA GENOTYPE OF INTEGRIN Β-SUBUNIT ArticleMaksimenko L.V., Moiseeva T.Yu., Tugarinova G.V., Karpova E.V., Frolov V.A., Itkes A.V.Bulletin of Experimental Biology and Medicine. Vol. 129. 2000. P.. 578-580
CLINICAL SYNDROMES IN PATIENTS WITH PANCREAS DESEASES ArticleMaksimov V.A., Chernyshev A.L., Neronov V.A.Справочник врача общей практики. 2010. P.. 46-55
CLINICAL TESTS IN THE DIAGNOSIS OF SCAPHOLUNATE LIGAMENT INJURIES ArticleGolubev I.O., Gazimieva B.M., Sautin M.E., Korolev A.V.Вестник травматологии и ортопедии им. Н.Н. Приорова. Vol. 30. 2023. P.. 385-392
CLINICAL TRIAGE OF PATIENTS ON KIDNEY REPLACEMENT THERAPY PRESENTING WITH COVID-19: AN ERACODA REGISTRY ANALYSIS ArticleMitra S., Jayanti A., Vart P., Coca A., Gallieni M., Øvrehus M.A., Midtvedt K., Gandolfini I., Büttner S., Franssen C.F.M., Hemmelder M.H., Essig M., Maas N., Vogt L., Jager K.J., Bemelman F.J., Klingenberg-Salahova F., Heenan-Vos F., Vervloet M.G., Nurmohamed A. ...NEPHROLOGY DIALYSIS TRANSPLANTATION. Vol. 36. 2021. P.. 2308-2320
CLINICAL TRIAL EFFICACY AND SAFETY OF BOTULINUM TOXIN A FOR UPPER LIMB SPASTICITY AFTER STROKE ArticleGalatonova YuliaModern Paradigm of the Scientific Knowledge: Actuality and Prospects: proceedings of the V International Multidisciplinary Scientific and Practical Conference in Foreign Languages. 2017. P.. 140-142
CLINICAL TRIAL OF FIBRINSELECTIVE THROMBOLYTIC PHARMACEUTICAL AGENT "FORTELYZIN®" (III PHASE) ArticleMarkin S.S., Semenov A.M., Markov V.A., Nizov A.A., Ponomarev E.A., Lebedev P.A.Вестник Российского университета дружбы народов. Серия: Медицина. 2012. P.. 105-110
CLINICAL TUMOR IMMUNOTHERAPY: RESEARCH ADVANCES ArticleMao J.P., Chen L.J.Journal of International Pharmaceutical Research. Vol. 40. 2013. P.. 127-136